Microvascular Coronary Artery Disease
26
3
4
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
2 terminated out of 26 trials
80.0%
-6.5% vs benchmark
4%
1 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (26)
A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction
Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA
AccuIMR Predicts Microvascular Obstruction and Infarct Size in STEMI Patients
Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.
Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function
Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics with Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM)
Study Comparing Two Administration Pathways for Adenosine During Microvascular Function Assessment
CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF
Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
Clinical Trial for Evaluating the Effectiveness and Safety of Online caIMR in STEMI Patients
Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI).
The MASTER-PACT Study
Coronary Sinus Pressure and Microvascular Disease
Evaluating Myocardial Ischemia in Chest Pain Using Exercise CMR
Simultaneous Assessment of Coronary Microvascular Dysfunction and Ischemia With Non-obstructed Coronary Arteries With Intracoronary Electrocardiogram and Intracoronary Doppler
Impact of TMAO Serum Levels on Hyperemic IMR in STEMI Patients
Additive Value of Physiology Coronary in Clinical Practice
Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus
A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI
Microvascular Coronary Resistance and Absolute Coronary FLOW in Patients With Percutaneous Intervention of a Chronic Total Occlusion